Strategic Plan Milestones vs. Incoming Mandate Trajectory
Interactive comparison of adopted strategic goals (2024–2028) against incoming 2026 executive focus milestones.
Committee Member Alignment & Expertise Topology
Interactive network graph illustrating federal agency representatives, public members, and incoming leadership ties.
Document & Statutory Mandate Compliance Ledger
Tracking statutory deliverables under the Autism CARES Act and executive transition reporting guidelines.
| Statutory Mandate / Provision | Target Phase | Responsible Working Group | Continuity Status | Risk Rating | Actions |
|---|
Board Transition Brief & Strategic Alignment Scorecard
Synthesized legal assessment for congressional committees, federal liaisons, and agency leadership.
Advisory Governance Profile
Quantitative Transition Metrics
- 68%
- Moderate (42%)
Transition Impact Findings & Regulatory Recommendations
1. Continuity of the 2024–2028 Strategic Plan: The committee's recent strategic roadmap outlines critical objectives in adult lifespan services, housing, and biomedical research. The incoming chair appointment preserves essential inter-agency links with NIH, CDC, and CMS while introducing strengthened emphasis on early screening and public health integration.
2. FACA Federal vs. Public Representation Balance: Historical precedent leans towards federal member stewardship for multi-agency execution. Transition protocols recommend establishing a joint Public-Federal Steering Subcommittee to maintain public advocate buy-in and prevent quorum or consensus dissolution during upcoming public sessions.
3. Immediate Milestone Actions: Finalize the Annual Summary of Advances in ASD Research and ensure the 2026 Portfolio Analysis deadline is met without administrative hold periods.